MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Enpatoran hydrochloride

CAS No. : 2101945-93-9

MCE 国际站：Enpatoran hydrochloride

产品活性：Enpatoran (M5049) hydrochloride 是一种有效的、具有口服活性的 TLR7/8 抑制剂，在HEK293 细胞中，其IC₅₀s 分别为 11.1 nM 和 24.1 nM。Enpatoran hydrochloride 对 TLR3, TLR4 和 TLR9 无活性。Enpatoran hydrochloride 可以阻断分子合成配体和天然内源性 RNA 配体。Enpatoran hydrochloride 在体内的表现出良好的药代动力学特性。Enpatoran hydrochloride 可用于先天性和适应性自身免疫阻断的相关研究。

研究领域：Immunology/Inflammation

作用靶点：Toll-like Receptor (TLR)

In Vitro: Enpatoran hydrochloride (0.01 nM-10 μM) inhibits production of IL-6 stimulated by all the ligands (miR-122, Let7c RNA, Alu RNA, and R848) with IC₅₀ values ranging from 35 to 45 nM.

In Vivo: Pre-treatment with Enpatoran hydrochloride (oral gavage; 1 mg/kg) before R848 (intraperitoneal injection of 25 µg) dose-dependently inhibits the production of IL-6 and IFN-α in mice.
Enpatoran hydrochloride exhibits high oral bioavailability (mouse 100%, rat 87%, dog 84%) following oral administration (mouse, rat and dog 1.0 mg/kg).
Enpatoran hydrochloride exhibits moderate half-lives (mouse 1.4, rat 5.0 and dog 13 h) due to high plasma clearance (1.4, 1.2 and 0.59 L/h/kg, respectively) combined with large volumes of distribution (2.7, 8.7 and 5.7 L/kg, respectively) following intravenous administration (mouse, rat and dog 1.0 mg/kg).

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Clinical Compound Library  |  Antiviral Compound Library  |  Small Molecule Immuno-Oncology Compound Library  |  Drug Repurposing Compound Library  |  Antioxidant Compound Library  |  Differentiation Inducing Compound Library  |  Oxygen Sensing Compound Library  |  Pyroptosis Compound Library  |  Targeted Diversity Library  |  Heterocyclic Compound Library  |  Pain-Related Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  C29  |  ODN 1018  |  TLR7 agonist 5  |  AN-3485  |  ODN 2088  |  TLR4/NF-κB/MAPK-IN-1  |  TLR9-IN-1  |  Complete Freund's adjuvant (CFA)  |  ODN 105871  |  MC-Val-Cit-PAB-Amide-TLR7 agonist 4  |  Monophosphoryl lipid A  |  β-D-Glucan  |  Poly (I:C):Kanamycin (1:1) (sodium)  |  ODN TTAGGG  |  Bropirimine  |  Polygalasaponin F  |  Chloroquine-d₅ diphosphate  |  DB-3-291  |  ODN 24888  |  ODN 2216  |  Agatolimod  |  BBIQ  |  UC-1V150  |  AZD8848  |  ODN 105870  |  CU-T12-9  |  TLR7/8 agonist 7  |  ODN 21158  |  TH1020

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

货号: HY-134581A

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。